| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  KT Tape Providing healthy solutions to the active consumer to prepare, perform, and recover. KT was founded in Utah in 2008 to provide breakthrough, drug-free solutions to athletes with its top tier kinesiology tape. Since then, we've become the market leader in our category in the US and now distribute our tape and other products globally. Our purpose is to empower movement to unleash every body's potential. As part of the KT team, you will help further our vision to become the leader in healthy solutions for active consumers to prepare, perform and recover for the activities they are passionate about. Purpose: … Type: | 8 | 2 | 2 | 74 |
 | IntuiTap Medical, Inc. At IntuiTap Medical, we are eliminating the guesswork, frustration, and pain from spinal punctures—procedures that are wrought with inaccuracy and inefficiencies. Our handheld, easy-to-use device is the world's first comprehensive solution that enables accurate spinal-needle placements for lumbar punctures, spinal anesthesia, epidurals, and drug delivery. Type: | 1 | 1 | 1 | 8 |
 | Quince Therapeutics Dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases Quince Therapeutics, Inc. is a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases. Our Phase 3 lead asset, EryDex, is the first product in development that leverages our proprietary Autologous Intracellular Drug Encapsulation, or AIDE, technology platform, which is a novel drug/device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells. Red blood cells have several characteristics that make them a potentially effective vehicle … Type: | 3 | 2 | 1 | 26 |
 | IMMvention Therapeutix, Inc. Interventions for Human Diseases Venture-funded company, discovering and developing oral novel small molecule first-in-class inhibitors of Bach1 (a transcription factor) as transformative potential therapy, globally accessible for patients with sickle cell disease (SCD), renal, cardiometabolic and neurodegenerative and other diseases. Sickle Cell Disease, fetal hemoglobin induction, beta-thalassemia, Renal diseases, cardiometabolic diseases, and neurodegenerative diseases Type: | 0 | 0 | 0 | 10 |
 | Intensity Therapeutics, Inc. A clinical stage biotechnology company whose mission is to create safer and more efficacious cancer therapies. Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected … Type: | 3 | 1 | 2 | 13 |
 | Magenta Therapeutics Developing novel medicines to bring the curative power of stem cell transplants to more patients Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients. Magenta is based in Cambridge, Mass. For more information, please visit www.magentatx.com. Follow Magenta on Twitter: @magentatx. Hematopoietic Stem Cell … Type: | 3 | 2 | 1 | 68 |
 | Arcturus Therapeutics A global mRNA medicines and vaccines company Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) is a global mRNA medicines and vaccines company with enabling technologies: (i) LUNAR® lipid-mediated delivery, (ii) STARR® mRNA Technology (sa-mRNA) and (iii) mRNA drug substance along with drug product manufacturing expertise. Arcturus developed Kostaive®, the first self-amplifying messenger RNA (sa-mRNA) COVID vaccine in the world to be approved. Arcturus has an ongoing global collaboration for innovative mRNA vaccines with CSL Seqirus, and a joint venture in Japan, ARCALIS, focused on the manufacture of mRNA vaccines and therapeutics. Arcturus’ … Type: | 4 | 1 | 2 | 204 |
 |  Casebia Therapeutics An innovative gene editing company discovering and developing curative treatments for genetic diseases Bayer and CRISPR Therapeutics have entered into an agreement to create Casebia to discover, develop and commercialize new breakthrough therapeutics to cure blood disorders, blindness, and congenital heart disease. CRISPR Therapeutics will contribute its proprietary CRISPR-Cas9 gene-editing technology and intellectual property, while Bayer will make available its protein engineering expertise and relevant disease know-how. It is the first long-term strategic partnership of its kind to make a substantial investment in the development of target delivery systems in an effort to bring systemic in vivo CRISPR-Cas9 gene editing … Type: | 0 | 0 | 0 | 2 |
 | Knip Our mission: Save (fish) lives, improve farm profitability, and contribute to a food-secure future. We are Knip (formally KnipBio), a women-led biotechnology company based in Boston, pioneering advanced nutritional solutions for animal feeds. Using a naturally occurring microbe, our precision feed ingredients are sustainably produced without reliance on arable land and minimal water use. aquaculture, agriculture, synthetic Biology, fermentation, and blue economy Type: | 3 | 1 | 3 | 4 |
 | Sana Health Relief made possible. Sana guides users into a deep state of relaxation, accelerating physical and mental recovery. Sana is a digital heath company driven by 25 years of research into relief for symptoms of chronic pain and insomnia. Sana is developing the first non-invasive, comfortable bio-therapeutic device capable of inducing a deep restorative state of relaxation to alleviate pain and tension. The device provides relief in just 10 minutes through the use of audio-visual neuromodulation, and is currently undergoing FDA certification and clinical trials. Chronic Nerve Pain, Chronic Pain, PTSD, Post Traumatic Stress Disorder, Stress, Anxiety, Sleep, Medical Devices, and … Type: | 5 | 1 | 2 | 23 |
 | RevBio, Inc. Transforming Bone Repair RevBio was started with one goal in mind—to end medicine’s 50 year search for a biocompatible bone adhesive. Effective for bone-to-bone as well as bone-to-metal wet field applications, Tetranite® is a revolutionary biomaterial that promises to transform bone repair—for both patients and clinicians. Inspired by the marine animal the sandcastle worm, Tetranite is simple chemistry. Bioengineered from the worm’s secreted protein, our synthetic adhesive is the only patented biomaterial which satisfies both the required and desired properties for a bone adhesive: wet field performance, multi-surface bonding, rapid mechanical stability, and controlled biodegradability. The properties of TetraniteTM include … Type: | 2 | 0 | 2 | 31 |
 | Molecular Templates Engineering the Next Generation of Therapeutics Molecular Templates, Inc. (MTEM) is a clinical stage biopharmaceutical company focused on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform with unique mechanisms of actions which are highly differentiated from antibody drug conjugates (ADCs). MTEM is developing MT-6402, which is in a Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients; MT-5111, which is in a Phase I clinical trial for the treatment of HER2-positive cancers; and MT-0169, … Type: | 1 | 1 | 0 | 55 |
 | Blueprint Medicines Striving to improve and extend patients' lives Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our … Type: | 10 | 1 | 6 | 729 |
 | C4 Therapeutics, Inc. Clinical-stage biotech company transforming how disease is treated through targeted protein degradation science C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO® platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve … Type: | 7 | 3 | 5 | 123 |
 |  Disease Diagnostic Group, Inc Disease Diagnostic Group, Inc is focused on screening, tracking, and diagnosing highly infectious or neglected tropical diseases through portable and reusable devices. Medical Device Design, Malaria, Infectious Disease, and Diagnostics Type: | 2 | 1 | 0 | 1 |
 | Fisher Wallace Laboratories, Inc. Better tech for mental health. Fisher Wallace Labs is on a mission to vastly increase access to mental healthcare. We develop and commercialize wearable brain stimulation technology for the treatment of depression, anxiety, and other neuropsychiatric and cognitive disorders. Our technology was recently proven to be rapidly effective in two large clinical trials for the treatment of Major Depressive Disorder and Generalized Anxiety Disorder, the latter of which was conducted in collaboration with the Seattle Police Department and Washington State University. Previous research includes a successful pilot study conducted at Beth Israel Hospital for the treatment of Bipolar II Depression, … Type: | 1 | 0 | 1 | 11 |
 | Akili Welcome to Akili! At Akili, we believe there is potential for medicine to be developed, delivered and experienced in a completely different way. We’re bringing together world-class neuroscience with exceptional creativity and video game development to challenge the status quo of medicine. Our digital medicine is not delivered through a pill, but rather through a patented and captivating video game experience. Effective medicine that’s captivating and enjoyable to use – now that’s refreshing! We're continuously evaluating new technologies and are advancing a broad pipeline of programs to treat cognitive deficiency and improve symptoms associated with medical conditions across neurology and … Type: | 11 | 2 | 8 | 133 |
 | FIECON Great Place To Work®. We're committed to making a positive difference in the lives of our people, clients, and society. FIECON was born out of the desire to make a difference in the world we live in – harnessing the power of health economics for the good of humanity. To date, we have donated over £900,000 to charitable causes. Our services: We provide services across the life cycle of a product and have worked in countries across the globe. Our key service areas comprise: • Outcomes Research • Economic Modelling • Health Technology Assessment • Value Communication • Pricing & … Type: | 0 | 0 | 0 | 113 |
 | GENOSKIN First-in-human data to accelerate drug development Genoskin is a pioneering contract research organization that leverages ethically sourced human skin to accelerate the development of biotherapies, vaccines, medical devices, and cosmetics. By integrating advanced technologies like transcriptomics, spatial biology, and bioinformatics with our ex vivo human skin models, we offer a robust platform for predicting compound efficacy and safety before human trials. Our models provide unparalleled insights into substance interactions, absorption, irritation, and overall skin response, reducing time-to-market and minimizing development risks. Committed to ethical research, we replace animal testing with human-relevant data, driving innovation in the biomedical, cosmetics, and skincare … Type: | 18 | 6 | 10 | 45 |
 | ReviveMed AI-based Metabolic Platform for Precision Medicine ReviveMed, an MIT spinout, develops an AI-based metabolomic platform and digital metabolic twins to simulate disease progression and treatment response. We advance genomics by leveraging crucial yet underexplored metabolite data, e.g., glucose or cholesterol, as our patented AI technology can characterize 20 times more metabolites and pioneer pre-trained generative models for metabolomics. We have growing precision medicine programs for oncology and cardio-metabolic diseases. In oncology, we have identified metabolic mechanisms regulating immune activity and a blood-based test of immune checkpoint inhibitor (ICI) response, addressing limited efficacy (<25% benefit), validated in renal cell carcinoma, where … Type: | 3 | 3 | 1 | 5 |
 | Orig3n COVID-19 testing, Wellness DNA Testing, Personalized Vitamins, and Regenerative Medicine Orig3n received Emergency Use Authorization clearance for their COVID-19 test on April 10, 2020. In addition to continuing work to provide the world with more knowledge about themselves based on their DNA, Orig3n is providing much needed COVID-19 capacity to nursing homes, boarding schools, clinicians, and underserved communities across the country. Orig3n helps people understand the links between their genes and how their minds and bodies work. From fitness to nutrition to personality, our DNA tests provide easy, affordable access to genetic information and guidance on how to use it. … Type: | 11 | 1 | 10 | 11 |
 | NGM Biopharmaceuticals Explorers on the frontier of life-changing science. NGM Bio is a biopharmaceutical company focused on discovering and developing novel, life-changing medicines for people whose health and lives have been disrupted by disease. The company’s biology-centric drug discovery approach aims to seamlessly integrate interrogation of complex disease-associated biology and protein engineering expertise to unlock proprietary insights that are leveraged to generate promising product candidates and enable their rapid advancement into proof-of-concept studies. As explorers on the frontier of life-changing science, NGM Bio aspires to operate one of the most productive research and development engines in the biopharmaceutical industry. All therapeutic candidates … Type: | 2 | 1 | 2 | 158 |
 |  BIOPHTA Changing the lives of patients suffering from chronic eye diseases ! World Health Organization evaluates between 200 and 300 million, the number of people who are visually impaired by diseases against which pharmaceutical treatments are however existing. Many of these conditions have in common to cause permanent vision loss if they are not treated consistently. The lack of adherence to prescription eye drops is the #1 Unmet Medical need in Ophthalmology. Poor treatment Compliance and Adhesion leads to a worse progression of Eye Diseases. BIOPHTA wants to change the lives of patients suffering from chronic eye diseases by creating a … Type: | 6 | 4 | 3 | 7 |
 | Selenium Medical Intuitive Innovation for Infection Prevention We believe that innovation is the key to success in Medical Device Market. Innovation, creation & patient well-being are in our DNA, we dare to go further, whether single-handedly or in partnership with our customers, while thinking outside the box thanks to our specialization and expertise in the medical industry. We can offer you our know-how, specific skills and expertise in technical consultancy for your projects in clean room injection, surface treatment and sterile packaging of your medical devices, through our different divisions SELENIUM Injection, SELENIUM Surface Treatment and SELENIUM Packaging. In all our divisions, … Type: | 12 | 1 | 10 | 46 |
 | Qubit Pharmaceuticals Anything is Druggable - with Quantum Accuracy Qubit Pharmaceuticals brings unparalleled accuracy and precision to drug discovery and design, using quantum physics to develop life-changing treatments for major diseases. No target is undruggable. Our proprietary technologies, the fruit of over 30 years of research, make it possible to develop novel drug candidates and innovative modes of action against targets previously considered too complex. Computational Chemistry, Molecular Dynamics Simulation, Quantum Physics, Drug Discovery, Drug Design, Quantum Computing, Quantum Chemistry, and HPC Tags: FrenchTech2030 Type: | 56 | 17 | 47 | 65 |
 | Overseed Medical cannabis: from seed to purified pharmaceutical grade active ingredients Overseed is the first French biotech company to obtain its license from the ANSM to start its R&D process on cannabis production for pharmaceutical purposes. We are a Biotech which combines leading expertise in genetics, agronomy, organic chemistry and pharma with the ambition to have an expert knowledge on the production of therapeutic cannabis. We will produce GACP and GMP certified dried flowers, full spectrum extracts and purified pharmaceutical grade active ingredients for laboratories. Overseed's research and experimentation will answer patients and the health industry expectations to guarantee production sovereignty, … Type: | 2 | 2 | 0 | 18 |
 | MOTEN Technologies Preventing risks of MSD by measuring muscular effort. MOTEN Technologies is a startup founded in 2018 and centered around a mission : to preserve the health and performance of men and women whose muscles constitute a precious and irreplaceable capital. After a year of development, we have prototyped and manufactured in France the first measurement technology «listening» the sounds produced by the muscles, revealing their level of effort and fatigue in any situation. Today, we support companies in various sectors whose operators are exposed to the risks of occupational diseases and accidents related to physical activity. Our clients seek to … Type: | 29 | 6 | 20 | 10 |
 | PHYSIDIA Physidia, a company founded in 2011 in Angers, France, is today known for its expertise in home dialysis. Right from the start, the company has made innovation its principal mission, helping home patients to find back their comfort and freedom on a daily basis. Thanks to the medical and para-medical expert opin¬ion, Physidia’s engineering team was able to create the S3 monitor, 100% dedicated to performance and safety. The S3 monitor is a portable machine dedicated to daily hemodialysis, simple to use, functions securely, and is discreet in appearance. Its development is based on multidisciplinary knowledge—that of our engineers, as … Type: | 12 | 1 | 5 | 72 |
 | OSCARE [Automatic translation follows] Together for our health OSCARE is the e-health solution for managing and organizing coordinated care pathways (ETP programs, HDJ/HDS, RAAC, SSR, etc.) for caregivers and their patients. OSCARE improves patient care by streamlining complex care pathways and making them actors in their health. Our digital service adapts to all pathologies or health themes: cancer, diabetes, obesity, maternity, Alzheimer's, Parkinson's, mental health, cardiology, pulmonology, tobaccology, pain management, etc. We meet a real national need in terms of prevention, diagnosis and health education. Come and discover our solution on www.os.care, or contact us for any questions at bonjour@os.care See … Type: | 5 | 1 | 4 | 7 |
 | Arterya The experts in the detection of the artery Normandy start-up based in Caen, we develop Blood'Up, a medical device that allows the instant detection of arteries. Type: | 31 | 11 | 28 | 15 |
 | SYNAXYS Accelerate drug development for neurological diseases SYNAXYS is French biotech specialized in the characterization of the response of the nervous system for nutraceutic, pharmaceutic and veterinary applications. We offer a complete range of R&D services to support drug development, from defining the dose effects in a human model, to identify biological targets and action mechanism, acute and chronic toxicity, or comparison to established treatments. Our field of application: - Drug positioning - Therapeutic evaluation in a diease model - Neuro-oncology - Data generation for IA modeling Neuro-engineering, Neuronal diseases modeling, Neuro-oncology, Autism, Alzheimer disease, and Glioblastoma Type: | 2 | 0 | 2 | 2 |
 | INNOVHEM Innovative science to improve the health of patients To adress the unmet need to dispose of relevant tools to value the efficacy of treatments for red blood cell disorders, INNOVHEM has developed two important and unique innovations :a simple and accurate method to quantify fetal hemoglobin in each red blood cell and a specific new method to measure intravascular hemolysis. Together with several generic biological assays, INNOVHEM offers a comprehensive and innovative platform that supports the development of new treatments for red blod cell pathologies, from preclinical to phase IV evaluation. Type: | 12 | 4 | 9 | 5 |
 | InFlectis BioScience Developpment of small molecules to prolong the protective effect of the Integrated Stress Response InFlectis BioScience is a private clinical-stage company aiming to target and modulate interactions between proteins involved in key human pathophysiological processes. The company is developing IFB-088 (INN: icerguastat), which specifically targets the Integrated Stress Response (ISR). Exploiting the ISR’s natural defense offers tremendous potential for the development of a new class of therapies. Led by InFlectis, this area of research is rapidly advancing, resulting in new treatments under development for a variety of diseases affecting the central nervous system (CNS), peripheral nervous system (PNS) and inflammation. … Type: | 2 | 2 | 0 | 9 |
 | AELIS FARMA A clinical stage biotech company opening a new frontier in pharmacology Aelis Farma is a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases. Aelis Farma is developing a new class of drugs: Signaling Specific inhibitors of the CB1 receptor (CB1-SSi) of the endocannabinoid system that provide access to several therapeutic areas without available treatments. These unique drug candidates, by reproducing a recently discovered natural defense mechanism of the brain , appear to be able to treat various brain pathologies without disrupting normal behavior. A first in pharmacology. Two initial drug candidates are already in clinical trials … Type: | 6 | 2 | 4 | 31 |
 | MindMaze France [Automatic translation follows] Specialized in Therapeutic Video Games and Digital Medical Devices. We are specialized in Therapeutic Video Games and Digital Medical Devices. Co-founder of LabCom BRAIN e-NOVATION with the Brain and Spine Institute. Type: | 18 | 0 | 18 | 3 |
 | Wespran Shaping the future of green biotech Wespran is a French climate deeptech startup specializing in synthetic biology and proteins. It is developing a turnkey biomimetic technology to upcycle industrial CO2 emissions into valuable products, starting with green methanol. At the forefront of biochemistry, physics, and bioinformatics, Wespran's clean biotechnology, FREED (Free Reactions using Enzymatic Electrocatalysis for Decarbonization), harnesses engineered enzymes. This innovative solution offers decarbonization as a service. By leveraging nature's power, Wespran helps industries reduce their carbon footprint while generating substantial profit. Target sectors include refineries, steel plants, chemical manufacturers, incinerators, cement factories, and thermal power plants. With a … Type: | 0 | 0 | 0 | 2 |
 | Faircraft Faircraft develops a highly sustainable, lab-grown alternative to animal leather. Faircraft develops a highly sustainable, lab-grown alternative to animal leather, based on advanced tissue engineering and material science techniques. Tags: FrenchTech2030 Type: | 5 | 5 | 0 | 16 |
 | EVEON Transforming Patient Experience EVEON aims to become international leader in the automatic preparation and delivery of therapeutic treatments to improve patient quality of life. As a partner of healthcare players, EVEON designs and manufactures technological, digital and user innovation products and services. Forward looking, EVEON places at the heart of its commitments social values of high standards that meet the challenges of personalized and participative medicine. EVEON focuses on business partnerships with a collaborative spirit of transparency and openness. EVEON develops a strategy based on ethical values of performance and adaptability to the needs of its clients. Type: | 15 | 3 | 14 | 18 |
 | Elysia Bioscience révélatrice du potentiel vivant Welcome to Elysia Bioscience, your key partner in the agroscience (crop protection) and natural cosmetics industry. Our mission is to REVEAL and ENHANCE the effects and modes of action of active ingredients or finished products on health and the environment 🌍. Specialized in cellular biology, Elysia Bioscience offers integrated solutions that combine proteomic analysis, bioinformatics, and scientific accessible communication. Our expertise facilitates cooperation between Research and Development teams, marketing departments, and also with end consumers. Together, we can create differentiating solutions that allow time efficiency and innovation. 🌞 👉Contact us to discuss about your projects! #InvitroTest … Type: | 13 | 4 | 11 | 7 |
 | Core Biogenesis The future of recombinant protein bioproduction. The future of recombinant protein bioproduction. Type: | 10 | 6 | 3 | 33 |
 | Tridek-One We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseases Tridek-One is a spin-off from Inserm that develops first-in-class therapeutic agonistic monoclonal antibodies targeting immune checkpoint inhibitory receptors for the treatment of autoimmune and inflammatory diseases. The company primarily focuses on the research and development of first-in-class anti-CD31 agonistic modalities designed to restore the immune balance. Anti-CD31 agonistic mAbs have the potential to provide targeted immunomodulatory activity with a favorable safety profile in diseases with high unmet clinical need. Tridek-One has initiated a discovery program which targets another ITIM receptor, fully leveraging its understanding of inhibitory checkpoint receptor … Type: | 0 | 0 | 0 | 16 |
 | Minos Biosciences Revolutionary single-cell analysis solution for fundamental, applied and clinical research and diagnostic. Minos Biosciences is on the path to bridge molecular and cell biology in a manner never achieved before that will, in turn, allow scientists to uncover the full picture of cell diversity and dynamics. By combining multi-omics analysis with phenotypic analysis at cell resolution and at high throughput, Minos’ solution provides a new paradigm in single-cell analysis that will open up new frontiers in life science research, precision medicine and diagnostics. Type: | 11 | 2 | 11 | 12 |
 | SMAIO Software, Machines and Adaptative Implants in Orthopaedics SMAIO (Software, Machines and Adaptative Implants in Orthopaedics) is a medical device manufacturer founded in 2009 by a group of spine surgeons having extensive experience in spinal pathologies treatment and a particular focus on patient sagittal balance restoration. SMAIO aims to provide surgeons with integrated spinal solutions (software, implants, services, instruments, etc.). Type: | 1 | 1 | 0 | 37 |
 | Okomera Automated 3D organoid screening technology We integrate standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug discovery from target to validation, and advance preclinical predictivity Type: | 24 | 8 | 15 | 23 |
 | SWAP Food Formerly Umiami | The tender, juicy whole filet made from plants. We make delicious, clean-label meat replacements from plants. Our first product, SWAP Filet (SWAP Chicken in the United States) is a thick, whole filet that closely replicates the taste, texture and appearance of chicken using a short list of familiar ingredients. From preparation to performance, SWAP Filet can replace chicken on any menu, enabling chefs to recreate classic recipes for modern times. Originally founded in France in 2020, we rebranded from Umiami to SWAP in 2024 to convey how simple it is for consumers and chefs to swap protein. … Tags: FrenchTech120 FrenchTech2030 Type: | 39 | 21 | 24 | 105 |
 | Institut Rafaël Santé Intégrative [Automatic translation follows] From the diagnosis, act in global health #InstitutRafaël Integrative Health "It is time to write the health of tomorrow! The Institut Rafaël Integrative Health is a project of general interest for adapted and personalized support for patients affected by chronic diseases ". Supportive care, nutrition, sports therapeutic education, psychologist, oncoesthetics Type: | 20 | 2 | 17 | 59 |
 | Home Biosciences A new breed of biotech company A new breed of biotech company aiming to unlock scientific breakthrough by leveraging an asset-centric operating model Type: | 10 | 5 | 6 | 7 |
 | Rime Bioinformatics Making high performance bioinformatics accessible. Rime Bioinformatics is a research and development biotechnology company with a focus on bioinformatics. We develop services to speed up medical, agronomic and veterinary research. Our technologies grant in-depth view of bacterial and bacteriophage genomes, which is an essential prerequisite in the R&D process that leads a phage to market. We work hard to make high-performance bioinformatics accessible and promote a safe use of phage therapy for the patients and the environment ! Bioinformatics, Phage, Bacteriophage, Genomics, Bacteria, Phage Therapy, and metagenomics Type: | 2 | 2 | 2 | 4 |
 | PEP-Therapy Innovative peptides as targeted therapies for oncology PEP-Therapy is a clinical-stage biotechnology company developing first-in-class peptides as targeted therapies in oncology. PEP-010, first drug candidate, is a pro-apoptotic agent which has demonstrated anti-tumor efficacy in a number of pre-clinical models and a good safety profile. PEP-010 is currently evaluated in a Phase Ia/b clinical trial in patients with recurrent and/or metastatic solid tumors. PEP-Therapy was founded in 2014 and builds on research results from Institut Curie and Sorbonne University. The company is backed by international investors. cell penetrating peptide, protein-protein interaction, targeted therapies, oncology, clinical trial, and cancer Type: | 5 | 4 | 2 | 15 |
 | LATTICE MEDICAL Specialising in tissue engineering and 3D printing, we develop innovative implants for soft tissue regeneration. Specialising in tissue engineering and 3D printing, we develop innovative implants for soft tissue regeneration using biomaterials. With the aim of providing patients with a better quality of care, Lattice Medical has developed two devices: MATTISSE, a 3D-printed resorbable breast implant, and RODIN, a matrix for regenerating the hypodermis. implant, breast reconstruction, aesthetics, tissue engineering, textile, biomaterials, 3D printing, breast cancer, Medical Devices, and filament for 3D printing Tags: FrenchTech2030 Type: | 51 | 18 | 42 | 24 |
 | GenSight Biologics Applying pathbreaking science to transform the lives of patients with severe retinal neurodegenerative diseases GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. GenSight Biologics’ pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence (MTS) and optogenetics for retinitis pigmentosa, to help preserve or restore vision in patients suffering from severe degenerative retinal diseases. GenSight Biologics’ lead product candidate, GS010, is in Phase III trials in Leber’s Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible low vision and legal blindness in … Type: | 16 | 6 | 11 | 38 |
 | Affilogic Discovering and developing Nanofitins® through collaboration with worldwide pharma industry leaders Affilogic is a private biotech company specialised in discovering and developing Nanofitins® through early-stage collaborations with worldwide industry leaders in the pharmaceutical sector. These affinity proteins are potent antibody-mimetics, exhibiting a high affinity and specificity for capture, targeting and interacting with biomolecules. Each Nanofitin® is 20 times smaller than an antibody (7 kDa) and demonstrates hyper stability. Nanofitins are easily combined with each other, antibodies and other biomolecules by simple, rapid and proven methods to design an ideal targeted molecule. Affilogic has designed Nanofitins® against 60+ targets to date, … Type: | 3 | 3 | 1 | 37 |
 | HAPPLYZ Medical - LORIO, respiratory rehabilitation 🎮 Breathe&Play, the new playful way to rehabilitate your respiratory system 🚀 Patented solution #videogames #medtech Step into the world of connected healthcare ! 394 millions people suffering from chronic respiratory diseases. Less than 10% of them regularly engage in respiratory rehabilitation, primarily due to lack of motivation. We have developed our first medical device from A to Z, LORIO, dedicated to monitored and gamified respiratory rehabilitation. LORIO is available in different versions for various purposes: at home, in medical practices, or collectively in rehabilitation centers. LORIO is a digital solution designed to improve the breathing capacity of these patients in … Type: | 50 | 15 | 41 | 5 |
 | Aker BioMarine ASA Aker BioMarine is a leading global innovator that develops krill-derived products for consumer health and nutrition Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. We bring our nutrient-rich, all-natural krill ingredient to the pharmaceutical and nutraceutical markets through our leading brands: Superba Krill Oil, Lysoveta, Understory, and Kori Krill. Our innovative approach also extends into our spin-offs FloraMarine (plant-based source of omega-3 from algae), AION (reduce and recycle plastic waste across industries), and Understory (our protein brand). The brand results from our belief that krill is an ancient natural … Type: | 9 | 1 | 7 | 335 |
 | Biomecanica [Automatic translation follows] Orthopedic implant and prosthesis industry with over 36 years of HISTORY, TRUST AND TRANSPARENCY. Founded in 1988, Biomecanica is headquartered in Jaú, in the interior of São Paulo, with one of the most advanced industrial parks in Latin America. Biomecanica has 120 employees, 1,000 products in production, 5,000 sub-items in production, not counting the products in the Stars line. Biomecanica invests in state-of-the-art machining equipment, in addition to having a laboratory in its infrastructure, with ISO 7 and ISO 5 quality certifications (aseptic mode) provided by ANVISA itself, for the production of biomaterials. With the partnership of … Type: | 0 | 0 | 0 | 181 |
 | SMICES SURGICAL You take care of others, we take care of you. SMICES is a european company based in Montpellier, which offers innovative, smart, and effective solutions, to the challenges encountered in the medical and surgical field. SMICESs commitment: improve the well-being of surgical teams and the safety in the operating theatre, in order to provide better patient care. SMICES works side by side with surgeons to develop the best medical devices, suitable for use in the operating room. For some years, the problem of the surgical smoke hazards during laparoscopy is raised. These smokes contain harmful substances and cause visual and … Type: | 5 | 2 | 1 | 2 |
 | AXIENCE S.A.S. [Automatic translation follows] Axience was created in 2001 and became a veterinary pharmaceutical operator in 2005. Portfolio of drugs, originators and generics, intended for pets, horses, cattle and pigs Very strong specialization in hygiene and disinfection of veterinary clinics since 2003 and in anesthesia and analgesia for all species since 2009. Anesthesia, Disinfection, Veterinary Biocides, and Analgesia Type: | 0 | 0 | 0 | 45 |
 | Theraclion Creators of extracorporeal robotic treatment platforms Theraclion is a French MedTech company committed to developing a non-invasive alternative to surgery through the innovative use of focused ultrasound. High Intensity Focused Ultrasound (HIFU) does not require incisions nor an operating room, leaves no scars, and allows patients an immediate return to their daily activities. Echotherapy, as the HIFU treatment method is called, concentrates therapeutic ultrasounds to an internal focal point from outside of the body. Theraclion has developed two CE-marked robotic platforms delivering echotherapy: SONOVEIN® for varicose veins and ECHOPULSE® for breast fibroadenoma and thyroid nodules. Each representing the potential to … Type: | 2 | 0 | 2 | 35 |
 | PHAXIAM Therapeutics Creating a global leader in extended phage therapies PHAXIAM is a biopharmaceutical company developing innovative treatments for resistant bacterial infections, which are responsible for many serious infections. The company is building on an innovative approach based on the use of phages, natural bacterial-killing viruses. PHAXIAM is developing a portfolio of phages targeting 3 of the most resistant and dangerous bacteria, which together account for more than two-thirds of resistant hospital-acquired infections: Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. PHAXIAM is listed on the Nasdaq Capital Market in the United States (ticker: PHXM) and on the Euronext regulated market in Paris … Type: | 15 | 5 | 8 | 84 |
 | Innate Pharma Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need. Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical … Type: | 21 | 9 | 14 | 195 |
 | AgeX Therapeutics, Inc. AgeX Therapeutics is focused on the development and commercialization of novel therapeutics targeting human aging. AgeX Therapeutics, Inc. (“AgeX”) is a biotechnology company focused on the emerging field of interventional gerontology. Its technology platform is built upon a modern understanding of the molecular basis of cellular immortality and regenerative biology. Leveraging technology licensed from parent company BioTime, Inc. as well as Geron Corporation, AgeX is leading the development of novel therapeutics targeting some of the largest market opportunities associated with an aging population. Type: | 0 | 0 | 0 | 12 |
 | UNITY Biotechnology UNITY is harnessing pathways of aging biology to develop new medicines, with a focus on retinal diseases. As pioneers in cellular senescence, UNITY is advancing the first senolytic therapeutic candidate for retinal diseases that aims to restore diseased tissue to a healthier state, a potentially paradigm shifting treatment in ophthalmology. Type: | 2 | 1 | 1 | 32 |
 | BrainXchange Your source for all things XR, digital twins, AI, and emerging tech in enterprise BrainXchange is a world-class conference organizer and thought leader in the enterprise AR/VR/MR (XR), digital twins, AI, and related emerging enterprise technology space. B2B Events, Augmented Reality, Virtual Reality, Tech Expo, Mixed Reality, Exoskeletons, Internet of Things (IoT), Enterprise Mobility, Emerging Technology, Metaverse, Spatial Computing, Digital Twins, Artificial Intelligence, Enterprise Technology, Digital Transformation, Future of Work, XR, and Extended Reality Type: | 96 | 0 | 96 | 9 |
 | APOLO Biotech Developing RNA's technologies Development of RNA-based technologies to enhance the productivity of crops (mainly intensive) which are respectful towards the environment and human health. Our OGM-free technology allows us to immunize crops against specific pathogens (fungi, insects, viruses), as a sort of "vaccine". In addition, we know how to modulate crop development, its response to the environment or the accumulation of metabolites of interest by designing RNAs as exogenous bioactive molecules to modulate the activity of plant genes. Fruits, Biotech, RNA, ARN, Plants, Vegetables, and Crops Type: | 2 | 0 | 2 | 30 |
 | BigHat Biosciences BigHat Biosciences is a novel protein therapeutics company and developer of an AI-guided antibody design platform BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases. BigHat is backed by Section 32, Andreessen Horowitz, 8VC, Amgen Ventures, Bristol Myers Squibb, Quadrille, Grids … Type: | 19 | 0 | 19 | 107 |
 | Paige Bridging Vision & Precision Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a global scale. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The same Paige technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options. Learn … Type: | 10 | 1 | 6 | 98 |
 | Enveda Biosciences Engineering New Drugs from Nature At Enveda, we are systematically translating molecules found in medicinal plants into new drugs for challenging diseases. Our platform harnesses nature's complexity with the help of cutting-edge advancements in knowledge graphs, machine learning, and metabolomics. Type: | 4 | 0 | 4 | 248 |
 | Generate:Biomedicines Pioneering generative biology to create breakthrough therapeutics. Pioneering generative biology to create breakthrough therapeutics. Type: | 13 | 0 | 12 | 319 |
 | Ranomics Ranomics offers innovative solutions for protein engineering, drug discovery, genomics research and synthetic biology Ranomics offers high throughput solutions for protein engineering, drug discovery, genomics research and synthetic biology. Using our VariantFind and VERG genomics platforms, Ranomics offers partners the a scalable solution to engineer and screen genetic variants in a wide range of model organisms. Our industry leading DNA Variant libraries and high-throughput cell assays help researchers to hit their research objectives faster and with better results than traditional methods. Over the years, we have worked with top biotech and pharma companies in the US and worldwide. Our partners … Type: | 0 | 0 | 0 | 5 |
 | Theranica A new era in migraine therapy Theranica is a neuromodulation therapeutics company dedicated to creating effective, safe, affordable, and low-side-effect therapies for idiopathic pain conditions. Our initial focus is on migraine, one of the most common neurologic disorders affecting over 1 billion people, with a high prevalence and morbidity, especially among adolescents and females. The company’s award-winning flagship Nerivio® REN wearable is changing the game for migraine sufferers, especially the 100 million adolescents facing this complex and non-curable disease. Nerivio is the first and only REN wearable that harnesses the natural power of the brain to shut off migraine symptoms … Type: | 3 | 0 | 2 | 72 |
 | TolerogenixX GmbH The Smart Way to Immune Tolerance TolerogenixX vision is to innovate Immunosuppression with its newly developed MIC Cell Treatments. MIC Cell Treatment is a curative ATMP approach to achieve a sustained regulation of the immune system in Transplant - and Autoimmune Disease Patients. TolerogenixX has been able to generate strong pre-clinical as well as clinical data in the indications of Transplantation and Autoimmune Diseases e.g. SLE since its foundation in 2016. Type: | 0 | 0 | 0 | 5 |
 | Stemcentrx, Inc. Founded in 2008, Stemcentrx combines state-of-the-art research and GMP manufacturing capabilities. This has allowed us to advance from target discovery in our laboratory to treating patients in clinical trials at an accelerated pace. We are investigating many of the largest and most lethal cancers through our proprietary platforms that identify cancer stem cells, discover novel targets, engineer and manufacture antibodies and antibody drug conjugates. Our mission is to develop therapies that cure and significantly improve survival for cancer patients. We are pioneering new approaches to eliminate cancer stem cells, which initiate and perpetuate tumors. Stemcentrx has assembled a talented and … Type: | 1 | 1 | 0 | 7 |
 | Halo Join a community of scientific experts working together to bring new innovations to the world Halo is a partnering platform that helps corporate R&D teams discover new technologies, build relationships with the researchers and startups behind them, and more efficiently scale external partnerships globally through the power of networks and AI. Since launching in January 2020, more than 7,000 universities from 135+ countries have joined the platform. In 2021, Halo was recognized as one of Fast Company's 2021 World Changing Ideas. On Halo, corporate R&D divisions post areas of interest for research collaborations (ie. Request-For-Proposals) and interested parties (scientists, startups, … Type: | 11 | 1 | 10 | 162 |
 | Aratana Therapeutics Inc. Aratana Therapeutics is a wholly owned subsidiary of Elanco Animal Health. Aratana Therapeutics, Inc. (Nasdaq: PETX) is a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats. Our mission is to successfully develop and deliver best-in-class therapeutics, provide comprehensive service to veterinarians and serve as a collaborator of choice for human and animal health companies. We believe our therapeutics are highly differentiated, resolve recognizable needs in compelling markets and have therapeutic profiles superior to the standard of care. Our FDA-approved and commercially available therapeutics include: - A prostaglandin receptor antagonist that specifically targets … Type: | 2 | 0 | 0 | 16 |
 | NeurologyLive Neurology Live is your trusted news source for breaking drug approvals, pipeline trials and emerging trends in neurology. The digital and print publication provides physicians and other healthcare professionals with up-to-date disease-specific news, clinical information and other resources that can help them provide better care to patients. At Neurology Live, you'll find in-depth conference coverage and information about upcoming meetings, content from our affiliated print journals, video interviews with leading physician experts and other multimedia resources. Get all the latest news on individual medical conditions in our condition centers: • Dementia & Alzheimer Disease • Epilepsy • Headache & Migraine … Type: | 6 | 0 | 5 | 1 |
 | Bionic Power Inc. Stand Taller. Walk Stronger.TM The AgilikTM is a smart, powered orthotic designed to improve gait for numerous conditions. Bionic Power’s purpose is to design and develop lower-body smart orthoses that improve quality of life by enhancing personal mobility and walking abilities. Stand Taller, Walk StrongerTM The AgilikTM smart orthosis helps patients retain or increase their independence and mobility. This is especially critical in children with knee-extension-deficiency disorders (typically from Cerebral Palsy, Spina Bifida, etc.) whose strength and endurance often deteriorate as they get older. The AgilikTM functions by assisting or resisting knee extension and flexion throughout the gait cycle. Approximately … Type: | 2 | 0 | 1 | 24 |
 | PK MED Tailor-designed drug implants for local treatments. Founded by Truffle Capital. PK MED is a French innovative biotech company, privately owned and established in 2019 with the support of Truffle Capital, a European Venture Capital firm specializing in Life sciences. PK MED was created around a small team of passionate and experienced experts in pharmaceutical and medical sciences, drug delivery and biomaterials design. PK MED specializes in the innovative development of custom-designed, injectable, and biodegradable micro-implants. Our expertise spans across critical healthcare domains, focusing on drug delivery systems for rheumatology and enhancing cell-homing techniques to improve bone marrow transplantation outcomes. The … Type: | 5 | 1 | 4 | 10 |
 | Aroma Therapeutics Un ingrédient alimentaire innovant à base de clou de girofle pour la santé cognitive Aroma Therapeutics is a biotech company specialised in natural products for the prevention of brain diseases. Aroma Therapeutics has patented a scent diffusion technology for Olfactory Deep-Brain stimulation. In collaboration with well-known laboratories, the company is working on an ethno-botanical approach for : •babie's pain relief •memory improvement and prevention of Alzheimer Disease The company also provides tools for Brain Function & Sleep Enhancement. Santé, Aromathérapie, Phytothérapie, Extraction de plantes, Compléments alimentaires, Santé Cognitive, Senior, Nutraceutique, maladies du vieillissement, alzheimer, Médecine Traditionnelle Chinoise, and Nutraceutique Type: | 15 | 6 | 6 | 7 |
 | AdhexPharma We deliver solutions AdhexPharma is an independent drug delivery company specialized in Transdermal & Topical patches and Oral Thin Films technologies. AdhexPharma is based in France, with GMP manufacturing facility for European and US market. We have 4 approved products in Europe and North America and a pipeline of 6 candidates, ranging from 505(b)2 / NDA and ANDA in different therapeutical areas: pain, CNS, anesthesia, smoking cessation and HRT. Trandermal, Patch, Oral Thin Film, Drug Development, GMP manufacturing, FDA approved, OTF, ODF, cGMP, TDS, CDMO, and CMO Type: | 7 | 2 | 3 | 127 |
 | Abolis Biotechnologies Decipher - Innovate - Build Abolis is a French company delivering high-impact innovations in biotechnologies that supports industries in their transition to build a better future in collaboration with Nature. We provide tailor-made industrial solutions based on micro-organisms. Founded in 2014, Abolis is made up of a team of over 54 people, sharing a scientific and humanist ambition. Determined to become a key player in the transformation of manufacturing, we combine our expertise in biology, fermentation, IT, robotics, analytics and industrial property to reinvent the future of numerous industries - from food to healthcare, cosmetics and chemicals. We help industries … Type: | 18 | 5 | 14 | 42 |
 | Inneolab [Automatic translation follows] Design products that meet user expectations and reveal the company's values. Are you in charge of the product offering, do you want to improve sales and limit the risks of commercial failure? An essential point A product can be functional, marketed at a price consistent with its market and yet sell poorly or receive mediocre reviews. Beyond the function, the product must meet customer expectations. If it does not make people want it, if it does not inspire confidence, if it does not respond to unspoken questions that are more subtle than the function, buyers will turn … Type: | 9 | 4 | 6 | 1 |
 | Epigene Labs augmented intelligence for precision oncology research and drug development Epigene Labs is creating the intelligence-augmenting solution for precision oncology research and drug development. Designed by cancer scientists for cancer scientists, the company's mCUBE platform accelerates data-driven drug discovery, biomarker identification, and patient selection -- to bring better treatments to patients faster. Based in Paris and Boston, Epigene Labs was initially incubated at the Harvard Innovation Labs and launched in France with the support of prominent European investors. Epigene Labs has partnerships with world-class cancer research institutes and biopharmaceutical companies. Type: | 10 | 4 | 7 | 33 |
 | PhinC Development 15 ans de modélisation en pharmacologie appliquée au développement des candidats-médicaments PhinC Development is the PK Modeling & Simulation partner for small to medium sized pharmaceutical or biotech companies, who need to move forward in early drug research. Based on Model-Informed Drug Development, PhinC helps you to increase the confidence in decision making and reduces cycle time of your development. Our mission consists in developing the best models to take advantage of all the research data at every phase (in vitro, in vivo animal and human) and carry out robust simulations and predictions requested and recommended by the regulatory authorities … Type: | 8 | 2 | 5 | 16 |
 | La Picorée [Automatic translation follows] Our purpose is to bring pep and joy to malnourished people and those at risk of malnutrition! La Picorée is a nutritional alternative for people at risk of malnutrition, particularly people with cancer and the elderly. We offer a new way of eating with Pep's, nutritional supplements "to nibble", high protein and high calorie, (finally!) delicious and natural! Our products are particularly adapted to the nutritional needs and uses of the elderly and sick. They are in a "small bite" format, suitable for eating by hand and chewing disorders. Discover our products through the "Pep's Experience", a … Type: | 10 | 3 | 2 | 5 |
 | AIOVA [Automatic translation follows] Vaccines for the future Based on an innovative, patented technology, AIOVA aims to develop and market innovative vaccines with high added value to its pharmaceutical industrial customers. AIOVA is positioned in the fight against emerging or re-emerging and deadly pandemics in humans and animals, in a OneHealth approach, and in particular influenza (human and avian flu), AIDS-type diseases, and, very recently, diseases caused by coronaviruses such as SARS-CoV-2, responsible for the current COVID-19 pandemic. The vaccines are designed from a patented DNA platform and have the properties of activating, in the vaccinated host, not only the production … Type: | 0 | 0 | 0 | 1 |
 | SAS Nutrivet Groupe [Automatic translation follows] The call of nature Created in 2004, Nutrivet positions itself as an expert in nutrition for dogs and cats. Born from a desire to provide healthy, tasty and suitable food for your beloved companion. Our products are guaranteed grain-free and rich in animal proteins in order to respect the original diet of dogs and cats. Proper nutrition is the guarantee of a long life for your pet dog. petfood, kibbles, dog, cat, and animal food Type: | 12 | 2 | 2 | 27 |
 | Diagnostics For Animals Federate and represent Manufacturers of Animal Health Diagnostics Promotes initiatives for the development of AHD Diagnostics For Animals is the only professional international #organization representing #animal #health #diagnostics. It federates and represents #manufacturers of animal health diagnostics at large, explains the benefit of an harmonized, efficient, and transparent regulatory framework to ensure the future #veterinary health industry and promotes initiatives for the development of animal health diagnostics health, animal, vet, veterinary, diagnostic, OneHealth, organization, livestock, pet, zoonosis, medical device, medical analysis, innovation, health security, research, and test Type: | 1 | 0 | 0 | 3 |
 | PANPHARMA [Automatic translation follows] A leading specialist in injectables A responsible and committed laboratory, our ambition is to be an independent European leader in the field of essential medicines. Our mission for 40 years: acting together, every day, to guarantee patients reliable access to essential medicines. We develop, produce and market generic injectable medicines for hospitals and clinics in France and in more than 75 countries on 5 continents. Through three production sites in France and Germany, we specialize in the fields of generic injectable antibiotics, anesthetics and analgesics. As a responsible laboratory, with a long-term vision, we have decided to … Type: | 2 | 1 | 1 | 458 |
 | Institut Carnot CALYM Consortium dedicated to partnership-based research on lymphomas CALYM is a consortium of organisations dedicated to lymphoma research, acknowledged as “Carnot Institute” since 2011: these are public/parapublic research institutes strongly committed to developing partnership-based research with the socio-economical sphere. CALYM was born from the wish shared by several research organisations to create a Consortium for the Acceleration of innovation and its transfer in the field of LYMphoma research. It currently includes 20 organisations with complementary expertise in preclinical, translational and clinical lymphoma research: 2 non-profit associations: – The Lymphoma Study Association (LYSA), a cooperating group that is the international leader of … Type: | 23 | 2 | 23 | 24 |
 | Carers in Hertfordshire We aim to ensure that all carers in Hertfordshire are recognised and valued; are informed and supported in their caring. Carers in Hertfordshire is concerned first and foremost to support unpaid carers, whatever the caring circumstances or the condition of the person receiving care. We support anyone who is caring, unpaid, for a family member or friend who is ill, elderly, disabled or has a physical or mental illness or who misuses drugs or alcohol. We aim to ensure that all carers in Hertfordshire are recognised and valued; are informed and supported in their caring role; have an opportunity for … Type: | 4 | 0 | 4 | 58 |
 | MDC Associates, Inc. Helping IVD innovators with RA/QA, FDA/CE submissions, CRO services, training, go-to and on-market support, and more. For more than 30 years MDC has helped innovators and entrepreneurs bring In Vitro Diagnostics (IVD) and Medical Devices to market that impact the lives of millions of patients around the world, every year. We support diagnostic makers and innovators by applying our expertise in Regulatory and Clinical Affairs, Quality Systems, and Data Management to help launch new advances that promote and protect the health of our global and local communities. regulatory, diagnostics, point of care, FDA, IVDR, quality systems, CRO, clinical trials, IVD, … Type: | 1 | 0 | 1 | 44 |
 | Greiner Bio-One International making a difference Greiner Bio-One specialises in the development, production and distribution of high-quality plastic laboratory products. The company is a technology partner for hospitals, laboratories, universities, research institutes, and the diagnostic, pharmaceutical and biotechnology industries. Greiner Bio-One has specialised in two business division, Preanalytics and BioScience. The Preanalytics business division, with headquarters in Kremsmünster (Austria), develops and produces innovative collection systems for human and veterinary blood, urine and saliva samples, with the aim of making day-to-day, routine tasks in hospitals, laboratories and doctors’ practices easier and safer. This division also covers customised software solutions (Greiner eHealth Technologies) which ensure … Type: | 2 | 0 | 0 | 542 |
 | Certest Biotec, S.L. Products and solutions for Raw Materials, Diagnostics and Pharma. MORE THAN DIAGNOSTICS! Highly specialized and customer-oriented, Certest Biotec consists of four divisions, including Raw Materials, Immunodiagnostics (Rapid Tests, Turbidimetry, and CLIA), Molecular Biology under the VIASURE brand, and Pharma. Certest Raw Materials provides high quality solutions for developing and manufacturing your IVD assays. Our expertise in protein expresión & purification, monoclonal antibodies develoment & manufacturing and primers & probes manufacturing offer to our customers a priceless support in their challenging proyects. Certest Immunodiagnostic -Rapid Test, Turbidimetry, CLIA- is committed to providing a comprehensive portfolio of diagnostic reagents for detecting infectious … Type: | 0 | 0 | 0 | 216 |
 | Biomedal Bioinnovation at your service. Biomedal S.L is a biotechnology company whose mission is to develop and commercialize new technologies, services and products for research, bioindustry and diagnostics. The company develops its activities in two areas: Biomedal Life Sciences and Biomedal Diagnostics. Biomedal Life Science is devoted to the development and commercialization of products and services for life sciences research, and technology for industrial bioprocesses. Its own technology allowed the improvement of recombinant protein production.Biomedal Life Science also functions as a CRO (Contract Research Organization) and provides services and support to pharmaceutical or biotechnology companies. Biomedal Diagnostics offers a large variety … Type: | 1 | 0 | 0 | 29 |
 | Ingenza Ltd ADVANCED BY NATURE. ADVANCED BY NATURE® Ingenza is a dynamic CRDMO whose understanding of nature and unique engineering biology toolbox, accelerate the customer journey through key milestones to commercial success. We engineer biological systems to make everything from therapeutics to enzymes and consumer products, addressing challenges in human health and the global environment. Enzyme Discovery, Enzyme Evolution, Molecular Biology, Protein Synthesis, High Throughput Screening, Strain Engineering, Fermentation, Process Development, and Synthetic Chemistry Type: | 3 | 0 | 3 | 45 |
 | Owen Mumford Innovation in healthcare solutions. We are an industry leader in the medical device market with a diverse product range including advanced automatic injection devices for drug delivery and innovative blood sampling products including lancets, lancing devices and safety lancets. Established in 1952 by Ivan Owen and John Mumford, we have 70 years of experience with offices, manufacturing sites and distributors located around the globe. Our corporate headquarters are located in Woodstock, Oxford UK. We are dedicated to providing innovative healthcare solutions for the management of a variety of medical conditions. With one of the most advanced global research, design and … Type: | 3 | 0 | 3 | 420 |
 | BPGbio, Inc. #AI #biopharma #therapeutics #mitochondrial #proteinhomeostasis #oncology #neurology #raredisease #drugdiscovery BPGbio is a leading biology-first AI-powered clinical stage biopharma focused on mitochondrial biology and protein homeostasis. The company has a deep pipeline of AI-developed therapeutics spanning oncology, rare disease and neurology, including several in late-stage clinical trials. BPGbio’s novel approach is underpinned by NAi, its proprietary Interrogative Biology Platform, protected by over 400 US and international patents; one of the world’s largest clinically annotated non-governmental biobanks with longitudinal samples; and exclusive access to the most powerful supercomputer in the world. With these tools, BPGbio is redefining how patient biology can be … Type: | 11 | 2 | 7 | 71 |
 | Zeta Farmaceutici Group [Automatic translation follows] Pharmaceuticals and cosmetics: two great Italian traditions. We renew them every day. Zeta Farmaceutici Group is an Italian industrial company formed by a group of companies specialized in the development, production and distribution of drugs, medical devices, cosmetics, food supplements, biocides. 1. Production and marketing of products with its own brands. Our brands are present in 10,000 pharmacies and parapharmacies, with widespread distribution throughout Italy. 2. Contract manufacturing. Industrial partnership with national and international companies and groups. Our brands. Euphidra. Make up, dermoscomesi, hair coloring, personal hygiene. Amido Mio. The rice starch line to cleanse and protect … Type: | 0 | 0 | 0 | 151 |
 | Excelya Expertly delivering clinical trials operations, with care. Excelya is an independent partner that serves Biotech, Pharma, and Medical Device organizations with a comprehensive range of Full-service CRO, FSP, and Resourcing solutions guided by compassion, care, and excellence. Founded in 2014 and headquartered in Paris, France, and operating in 28 countries across Europe, USA and India, Excelya has a global team of 900+ experts who understand the critical needs of clients to provide bespoke and robust trial solutions across a broad spectrum of therapeutic areas, with speciality focus on Oncology & Hematology, Rare Disease & Pediatrics, Infectious Disease, Inflammation & Immunotherapy, … Type: | 8 | 2 | 3 | 717 |
 | Genomic Vision Genomic Vision is a French biotech providing tools and services to visualize and characterize single DNA molecules. GENOMIC VISION develops novel diagnostic and drug discovery solutions based on its world-leading nanotechnology for DNA analysis in the areas of cancer and acute diseases. These diagnostic tests and drug discovery tools operate where genome dynamics and human disease intersect. GENOMIC VISION uses a powerful technique, Molecular Combing Technology, for the direct visualization of single DNA molecules to detect quantitative and qualitative changes in the genome landscape and establish their contribution to pathology. GENOMIC VISION initial focus is towards early cancer detection and … Type: | 3 | 1 | 0 | 19 |
Startup